These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3086830)

  • 21. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
    Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
    Fay MA; Sheth RD; Gidal BE
    Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
    Kradolfer F; Schnell R
    Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
    [No Abstract]   [Full Text] [Related]  

  • 24. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT; Vakhmistrova TI; Perova TL
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rapid intravenous administration of isoniazid in treating newly detected destructive pulmonary tuberculosis].
    Shchutskaia EI; Khlebnikova LA; Derbikova TI; Ivanova GT
    Probl Tuberk; 1980 Feb; (2):41-4. PubMed ID: 7375460
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum and cerebrospinal fluid concentrations of rifampicin at two dose levels in children with tuberculous meningitis.
    Mahajan M; Rohatgi D; Talwar V; Patni SK; Mahajan P; Agarwal DS
    J Commun Dis; 1997 Sep; 29(3):269-74. PubMed ID: 9465533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of commercially prepared isoniazid diet to produce isoniazid serum concentrations in rhesus monkeys.
    Ringler DH; Miceli JN; Licht JM; Weber WW
    Lab Anim Sci; 1976 Aug; 26(4):581-5. PubMed ID: 823367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana).
    Maslow JN; Mikota SK; Zhu M; Isaza R; Peddie LR; Dunker F; Peddie J; Riddle H; Peloquin CA
    J Vet Pharmacol Ther; 2005 Feb; 28(1):21-7. PubMed ID: 15720511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary tuberculosis of the oral cavity].
    Junquera Gutiérrez LM; Alonso Vaquero D; Albertos Castro JM; Palacios Gutierrez JJ; Vicente Rodriguez JC
    Rev Stomatol Chir Maxillofac; 1996; 97(1):3-6. PubMed ID: 8628965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
    Mitinskaia LA; Elufimova VF; Iukhimenko NV; Pogodaeva NP; Iavorskiĭ KM
    Probl Tuberk; 1994; (6):16-8. PubMed ID: 7708637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifampin in treatment of tuberculous meningitis in children.
    Sunakorn P; Wongsaroj P
    J Med Assoc Thai; 1978 Feb; 61(2):93-8. PubMed ID: 632712
    [No Abstract]   [Full Text] [Related]  

  • 36. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
    Zwolska Z; Augustynowicz-Kopeć E; Niemirowska-Mikulska H
    Acta Pol Pharm; 2002; 59(6):448-52. PubMed ID: 12669769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
    Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
    Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.